Sarepta Therapeutics Newsroom

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Businesswire05:10

Express News | Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Breakings05:10

Sarepta Therapeutics Stock Surges 43% YTD: How to Play the Stock?

Zacks 02:00

Sarepta Price Target Lowered to $202 From $205 at Needham

Yahoo FinanceNov 28 21:15

A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $182 to $215

Futu NewsNov 28 21:00 · Ratings

RBC Capital Remains a Buy on Sarepta Therapeutics (SRPT)

TipRanksNov 28 09:46 · Ratings

Short Stock Ideas From Each Sector With Earnings Quality in the Bottom 20%

Seeking AlphaNov 28 01:16

Sarepta Therapeutics Is Maintained at Overweight by Piper Sandler

Dow JonesNov 28 00:37 · Ratings

SRPT Inks $11B Licensing Deal With Arrowhead for Rare Gene Therapies

Zacks Nov 28 00:00

Wall Street Analysts Think Sarepta Therapeutics (SRPT) Could Surge 42.11%: Read This Before Placing a Bet

Zacks Nov 27 22:05

A Quick Look at Today's Ratings for Sarepta Therapeutics(SRPT.US), With a Forecast Between $182 to $217

Futu NewsNov 27 21:00 · Ratings

Sarepta Therapeutics (SRPT) Gets a Buy From TD Cowen

TipRanksNov 27 20:36 · Ratings

Sarepta Therapeutics Receives Buy Rating From Gil Blum: Strategic Partnerships and Financial Stability Highlight Growth Potential

TipRanksNov 27 19:05 · Ratings

US stocks mining | Nuclear energy stocks collectively rise! CEG's annual increase is nearly 130%; aerospace stocks celebrate together! SpaceX's formidable rival Rocket Lab has surged over 360% this year.

Hundred-billion collaboration agreement finalized! Biotechnology company sarepta therapeutics surged nearly 14% overnight, approaching a three-month high; Medical reimbursement limit increased! Medical diagnostic company exact sciences rose 9% last night.

Futu NewsNov 27 18:43

Needham Maintains Buy on Sarepta Therapeutics, Lowers Price Target to $202

BenzingaNov 27 18:40 · Ratings

Sarepta Therapeutics Analyst Ratings

BenzingaNov 27 18:37 · Ratings

Sarepta Therapeutics: Strategic Expansion and Robust Pipeline Justify Buy Rating and $217 Price Target

TipRanksNov 27 18:26 · Ratings

Express News | Sarepta Therapeutics Inc : Piper Sandler Cuts Target Price to $182 From $200

BreakingsNov 27 15:56

Wolfe's Most Shorted 'Hit List' – FSLR, BE, WBA, SJM

Seeking AlphaNov 27 03:01

Trending Stocks Today | CIMG Soars 138.09%

November 26th - US stocks trending in regular trading hours.Gainers: $CIMG(IMG.US)$ surges 138.09% to $1.5 with a turnover of $76.79 million. $T Stamp(IDAI.US)$ shoots up 83.33% to $0.33 with a

Futu NewsNov 27 03:00